{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:41:09Z","timestamp":1791009669546,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.canlet.2006.07.003","type":"journal-article","created":{"date-parts":[[2006,8,22]],"date-time":"2006-08-22T08:03:03Z","timestamp":1156233783000},"page":"186-191","source":"Crossref","is-referenced-by-count":47,"title":["Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas"],"prefix":"10.1016","volume":"248","author":[{"given":"Michael","family":"Meister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Dienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild","family":"Mechtersheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A.","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Herpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Muley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Rieker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2006.07.003_bib1","series-title":"Histological Typing of Tumors of the Thymus. World Health Organization. International Histological Classification of Tumours","year":"1999"},{"key":"10.1016\/j.canlet.2006.07.003_bib2","series-title":"World Health Organization Classification of Tumours. Pathology and genetics of tumors of the Lung, Pleura, Thymus and Heart","year":"2004"},{"key":"10.1016\/j.canlet.2006.07.003_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00595-005-3047-y","article-title":"Thymoma and thymic carcinoma: an update of the WHO Classification 2004","volume":"35","author":"Strobel","year":"2005","journal-title":"Surg. Today"},{"key":"10.1016\/j.canlet.2006.07.003_bib4","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ijc.10255","article-title":"Histologic classification of thymic epithelial tumors: comparison of established classification schemes","volume":"98","author":"Rieker","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2006.07.003_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1378\/chest.127.3.755","article-title":"Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review","volume":"127","author":"Kim","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.canlet.2006.07.003_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.cco.0000152628.43867.8e","article-title":"Treatment of malignant thymoma","volume":"17","author":"Giaccone","year":"2005","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.canlet.2006.07.003_bib7","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Strobel","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2006.07.003_bib8","doi-asserted-by":"crossref","unstructured":"R.J. Rieker, S. Joos, G. Mechtersheimer, H. Blaeker, P.A. Schnabel, A. Morresi-Hauf, E. Hecker, M. Thomas, H. Dienemann, P. Schirmacher, M.A. Kern, COX-2 up-regulation in thymomas and thymic carcinomas, Int. J. Cancer (2006) July 5; [Epub ahead of print].","DOI":"10.1002\/ijc.22078"},{"key":"10.1016\/j.canlet.2006.07.003_bib9","unstructured":"A. Kurup, M. Burns, S. Dropcho, W. Pao, P.J. Loehrer, Phase II study of gefitinib treatment in advanced thymic malignancies. Presentated at the ASCO, Annual Meeting (2005) http:\/\/www.asco.org\/portal\/site\/ASCO\/menuitem.34d60f5624ba07fd506fe310ee37a01d\/?vgnextoid=76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abst_detail_view&confID=34&abstractID=30129."},{"key":"10.1016\/j.canlet.2006.07.003_bib10","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2006.07.003_bib11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.canlet.2006.07.003_bib12","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2006.07.003_bib13","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2006.07.003_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1574-6968.1999.tb13575.x","article-title":"BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences","volume":"174","author":"Tatusova","year":"1999","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.canlet.2006.07.003_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00194697","article-title":"Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21","volume":"426","author":"Hayashi","year":"1995","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2006.07.003_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jcp.48.5.447","article-title":"Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen","volume":"48","author":"Gilhus","year":"1995","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2006.07.003_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2559.1993.tb01181.x","article-title":"Expression of epidermal and nerve growth factor receptors in human thymus and thymomas","volume":"23","author":"Pescarmona","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2006.07.003_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cncr.20811","article-title":"Protein expression and gene amplification of epidermal growth factor receptor in thymomas","volume":"103","author":"Ionescu","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2006.07.003_bib19","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1158\/1078-0432.CCR-04-1853","article-title":"Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer","volume":"11","author":"Yang","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.07.003_bib20","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1200\/JCO.2005.09.985","article-title":"Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology","volume":"23","author":"Janne","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2006.07.003_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hed.10224","article-title":"Targeting epidermal growth factor receptor in head and neck cancer","volume":"25","author":"Ford","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2006.07.003_bib22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2004.00.1792","article-title":"Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm","volume":"24","author":"Pfister","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2006.07.003_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2006.07.003_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nri1331","article-title":"Developing a new paradigm for thymus organogenesis","volume":"4","author":"Blackburn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2006.07.003_bib25","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1200\/JCO.2005.01.2823","article-title":"Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study","volume":"23","author":"Hirsch","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2006.07.003_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jnci\/dji112","article-title":"Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer","volume":"97","author":"Cappuzzo","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2006.07.003_bib27","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1200\/JCO.2005.01.0793","article-title":"Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer","volume":"23","author":"Takano","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2006.07.003_bib28","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1074\/jbc.M211360200","article-title":"Differentiation status-dependent regulation of cyclooxygenase-2 expression and prostaglandin E2 production by epidermal growth factor via mitogen-activated protein kinase in articular chondrocytes","volume":"278","author":"Huh","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2006.07.003_bib29","first-page":"429","article-title":"Cyclooxygenase-2 is overexpressed in human cervical cancer","volume":"7","author":"Kulkarni","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.07.003_bib30","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1096\/fj.02-1011com","article-title":"Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors","volume":"17","author":"Pai","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2006.07.003_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm0302-289","article-title":"Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy","volume":"8","author":"Pai","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2006.07.003_bib32","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1158\/1078-0432.CCR-03-0677","article-title":"Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck","volume":"10","author":"Chen","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.07.003_bib33","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1158\/1078-0432.CCR-04-2102","article-title":"Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506004265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506004265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T15:33:28Z","timestamp":1555774408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383506004265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0304383506004265"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2006.07.003","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}